Sitting with Gladys and James was longtime volunteer Judy Schinkel who started donating her time at the Kordyban Lodge soon ...

Background Amyloid transthyretin (ATTR) amyloidosis is a rare, life-threatening disease frequently manifesting with ...

Detailed price information for Crispr Therapeutics Ag (CRSP-Q) from The Globe and Mail including charting and trades.

Additionally, in 2025, the U.S. Food and Drug Administration (FDA) approved 11 drugs based on clinical trials in which MSK played a pivotal role. “MSK’s clinical research teams made great progress in ...

The stock has lost significant market value since that debacle. While it's not clear that nex-z was responsible, it's also ...

Hematologists and oncologists from UC San Francisco shared research results and clinical guidance at the world’s premier meeting for malignant and non-malignant hematology at the American Society of ...

For the first time in coastal Karnataka at the corporate level, Yenepoya Speciality Hospital, Kodialbail, in association with ...

Alnylam Pharmaceuticals is to invest $250m to expand its facility in Massachusetts, US, to meet the growing demand for RNAi ...

Learn more about whether Halozyme Therapeutics, Inc. or Zymeworks Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Detailed price information for Immix Biopharma Inc (IMMX-Q) from The Globe and Mail including charting and trades.

Gene editing has rapidly evolved into a transformative class of technologies that allow scientists to precisely insert, ...

The drugmaker revised its revenue guidance for 2025, saying it now expects $62 billion in revenue for the year.